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To assess the relationship between interstitial capillary
density and interstitial macrophages we prospectively
measured these factors in situ in 110 patients with chronic
kidney disease. Macrophage numbers and urinary MCP-1/
CCL2 levels significantly correlated inversely with capillary
density which itself significantly correlated inversely with
chronic damage and predicted disease progression. In 54
patients with less than 20% chronic damage, there was a
significant correlation between the urinary albumin to
creatinine ratio and MCP-1/CCL2, and MCP-1/CCL2 and
macrophages but not between MCP-1/CCL2 and capillary
density. Conversely, in 56 patients with over 20% chronic
damage there was no correlation between MCP-1/CCL2 and
macrophages but there were significant inverse correlations
between capillary density and both macrophages and
chronic damage. The expression of VEGF mRNA significantly
correlated with macrophage infiltration, capillary density and
chronic scarring. In an ischemic-hypertensive subgroup there
was upregulation of the hypoxia marker carbonic anhydrase
IX and with over 20% chronic damage an increased
macrophage to CCR2 ratio. Our study shows that proteinuria
and MCP-1/CCL2 are important for macrophage recruitment
in early disease. As renal scarring evolves, alternative
pathways relating to progressive tissue ischemia secondary
to obliteration of the interstitial capillary bed predominate.
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The evolution of chronic kidney disease is characterized by
interstitial fibrosis and tubular atrophy. These changes are
promoted by interactions between resident tissue compo-
nents and infiltrating cells. Animal models and observational
studies in humans indicate that infiltrating macrophages have
a central role in the initiation and progression of renal
scarring.1 Irrespective of the initial insult, these processes
represent a common pathway for the development of injury
and progression to end-stage kidney disease.
There are a number of molecules involved in the
recruitment of macrophages in chronic kidney disease. We
have recently shown a role for the macrophage-directed
chemokine monocyte chemoattractant protein-1 (MCP-1/
CCL2) in a large prospectively recruited cohort of patients
with a heterogeneous group of chronic kidney disease: the
dominant role for this pathway was in patients with lower
levels of renal scarring.2 A role for MCP-1/CCL2 in renal
disease is further supported by smaller human studies and
animal models where disease is abrogated by blocking MCP-
1/CCL2 or CCR2.3–10 Interestingly these studies focused on
analysis and intervention in early disease.
Progressive tubulointerstitial disease is associated with the
loss of interstitial capillaries and a reduced blood flow within
those that remain.11–14 These observations indicate that the
renal cortex becomes more ischemic as chronic kidney
disease evolves and this may have a central role in disease
progression.15 A number of molecules may be differentially
expressed in situ in response to hypoxia in chronic kidney
disease.16 For example, vascular endothelial growth factor
(VEGF), a hypoxia-induced angiogenic factor,17 was ex-
pressed by renal tubules in human chronic kidney disease
with increased expression related to peritubular capillary
loss.12 Similar patterns were seen in a recent study on
human immunoglobulin (Ig)-A nephropathy.18 Other studies
have demonstrated increased tubular and interstitial cell
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expression of other proinflammatory and profibrotic mole-
cules in response to hypoxia.19,20 To date, however, the
relationship between renal hypoxia and macrophage recruit-
ment to the interstitium has not been studied in human
chronic kidney disease.
In these studies, we have analyzed a chronic kidney disease
cohort for interstitial capillary density as a surrogate marker
for tissue hypoxia. We have assessed the relationship between
interstitial capillary density, MCP-1/CCL2, macrophage
recruitment, and chronic damage, and analyzed the differ-
ential relationship between macrophage recruitment, albu-
minuria, and capillary density in respect of the stage of
chronic damage. Further, we have related these in situ
changes to VEGF mRNA levels, carbonic anhydrase IX (CA
IX) expression (a marker for in situ hypoxia), and the
differential expression of the chemokine receptors, CCR2 and
CX3CR1. These data indicate that the factors that promote
macrophage recruitment and retention at interstitial sites
may change as kidney disease progresses.
RESULTS
Patients
One hundred and ten patients were studied. This group
represented a cohort derived from a population of 215
patients who have previously been reported for index of
chronic damage, urinary MCP-1/CCL2, albumin-to-creati-
nine ratio (ACR), and interstitial macrophages.2 For this
study, we excluded all patients with (i) thin glomerular
basement membrane disease (n¼ 44); (ii) minimal change
nephropathy (n¼ 5); (iii) diabetic nephropathy (n¼ 18); (iv)
extensive background staining that prevented analysis of
tissue (n¼ 28); and (v) no cortex in the biopsy specimen
(n¼ 10). Table 1 summarizes the in situ data obtained for the
cohort.
Quantification of peritubular capillary density
Quantification of in situ determinants for potential bias was
assessed. There was agreement between measurements of
interstitial numbers by the same observer (mean 1.00; 95%
CI: 0.98–1.06) or measurements by two observers (mean 0.97;
95% CI: 0.96–1.12). The limits of agreement of measurements
by the same observer were 0.85 (CI: 0.79–0.91) and 1.19 (CI:
1.11–1.28), and the limits of agreement of measurements by
two observers were 0.69 (CI: 0.60–0.78) and 1.35 (CI:
1.18–1.55).
Peritubular capillary density and macrophage colocalization
There was a uniform distribution of capillaries between
tubules in renal tissue without evidence of tubulointerstitial
damage (Figure 1a). This was associated with low numbers of
interstitial macrophages that were evenly dispersed through-
out the interstitium (Figure 1b). Loss of interstitial capillaries
was associated with increased interstitial macrophage num-
bers. Where tubulointerstitial disease was patchy, reduced
density of capillaries (Figure 1c) colocalized with increased
interstitial macrophage numbers (Figure 1d). In biopsies with
an advanced stage of scarring, there was generalized
interstitial capillary loss and increased interstitial macro-
phage numbers.
Capillary density correlates with MCP-1/CCL2, interstitial
macrophages, and chronic damage
By univariate analysis, capillary density inversely correlated
with urinary MCP-1/CCL2 levels (correlation¼0.28, P¼
0.005), interstitial macrophage numbers (correlation¼0.621,
Po0.001), and index of chronic damage (correlation¼
0.82, Po0.001) (Figure 2). There was no correlation with
ACR (correlation¼0.068, NS).
Capillary density and renal outcome
Kaplan–Meier survival analysis found that those patients with
least interstitial capillary density had the worst renal outcome
(Figure 3). Univariate Cox regression analysis found inter-
stitial capillary density to significantly impact on renal
outcome (exp B¼ 0.674, P¼ 0.001). The impact of the other
clinical and pathological variables on renal survival as
assessed by Kaplan–Meier analysis has been previously
described.2
Table 1 | Study population: Clinical, pathological, and experimental characteristics
Histological diagnosis (n)
Age
(years)
Interstitial
capillaries (%)
Index of chronic
damage (%) ACR (mg/mmol)
Urinary MCP-1/CCL2
(pg/mg)
Interstitial
macrophages (%)
Ischemic/hypertensive
nephropathy (37)
56 (28–81) 6.0 (2.4–11.3) 40 (0–97) 23.8 (0.0–436.6)
(n=36)
181.5 (13–845.3)
(n=33)
2.0 (0.9–4.5)
(n=36)
IgA nephropathy (29) 37 (23–87) 10.3 (2.7–12.6) 9 (0–94) 19.8 (0.4–1097.3) 114.9 (10.6–981.7)
(n=27)
1.1 (0.8–4.2)
(n=26)
Focal segmental
glomerulosclerosis (20)
49 (30–73) 8.1 (4–11.8) 19.5 (0–75) 345.9 (49.8–1053.4)
(n=19)
394.9 (41.5–1118.8)
(n=17)
1.8 (1.1–4.5)
(n=18)
Other GN (12) 43 (20–71) 10.6 (5–13.3) 8 (0–79) 201.3 (1.8–890.9)
(n=11)
161.8 (16.9–652.7)
(n=11)
1.7 (0.9–6.1)
Amyloid/light chain
disease (6)
79 (52–85) 7.2 (3.9–9.4) 37.5 (19–93) 91.7 (16–848.4) 510.8 (172.9–737.5)
(n=5)
3.3 (1.8–7.5)
Others (6) 51 (29–80) 8.8 (5.8–11.6) 27.5 (0–59) 14.3 (0.5–379.1) 155.2 (11.7–604.8)
(n=5)
1.0 (0.9–5.3)
(n=5)
ACR, albumin-to-creatinine ratio; GN, glomerulonephritis; IgA, immunoglobulin-A; MCP-1/CCL2, monocyte chemoattractant protein-1. Results are shown as median
(range).
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Linear regression analysis
Multivariate linear regression analysis was used to assess the
relationship between capillary density, interstitial macro-
phage numbers, urinary MCP-1/CCL2 levels, and ACR, with
chronic damage as the dependent variable. There was a strong
independent negative correlation between capillary density
and chronic damage (0.574; Po0.001) and an independent
positive correlation between macrophage numbers and
chronic damage (0.363; P¼ 0.001). There was no correlation
between urinary MCP-1/CCL2 levels and chronic damage
(0.035; NS), and no correlation between ACR and chronic
damage (0.063; NS).
The relationship between albuminuria, capillary density,
and chronic damage
We have previously shown that over a mean follow-up period
of 832 days, the index of chronic damage was a major
determinant of renal survival.2 In patients with an index of
chronic damage of less than 20%, 2% of patients reached a
renal end point, as defined by doubling of serum creatinine
or reaching end-stage renal failure. This is comparable to
26% of patients with an index of chronic damage of 20% or
more reaching the renal end point.
To assess the differential relationship of albuminuria
and capillary density with chronic damage, macrophage
infiltration, and urinary MCP-1/CCL2, subset analysis was
performed for patient groups based on the index of chronic
damage. Group 1 (n¼ 54) comprised patients with biopsies
with chronic damage of less than 20%; Group 2 (n¼ 56)
comprised patients with biopsies with chronic damage of
20% or more.
Albuminuria and chronic damage
Albuminuria was correlated with chronic damage in Group 1
(correlation¼ 0.337; P¼ 0.015), but there was no correlation
with worsening advanced chronic damage (Group 2) (Table 2;
Figure 4). Similarly, there was a correlation between
albuminuria and macrophage numbers in Group 1
(correlation¼ 0.619; Po0.001), but no correlation in
Group 2. There was no correlation in Group 1 or 2 between
albuminuria and capillary density.
Albuminuria correlated with urinary MCP-1/CCL2 levels
in Group 1 (correlation¼ 0.529; Po0.001) and Group 2
(correlation¼ 0.483; Po0.001).
Capillary density and chronic damage
Capillary density was negatively correlated with chronic
damage in Group 1 (correlation¼0.281; P¼ 0.04) and
a b
c d
Figure 1 | Capillary loss and macrophage colocalisation.
Capillaries (a, c) by anti-CD34 and macrophages (b, d) by anti
CD68 in renal biopsies, paired serial sections, no counterstaining.
No damage, Mild IgA nephropathy (a, b); (uniform distribution of
capillaries and macrophages). Moderate damage, ischemic renal
disease (c, d); patchy (inset box) decreased capillary density and
increased macrophage numbers.
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Figure 2 | Capillary density correlations. Plots of correlations
(correlation; P-value) between (a) interstitial capillary density and
urinary MCP-1/CCL2 (0.28; o0.005), (b) Macrophage numbers and
interstitial capillary density (0.64; Po0.001), and (c) interstitial
capillary density and index of chronic damage (0.82; Po0.001).
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strongly negatively correlated in Group 2 (correlation¼
0.562; Po0.001) (Figure 4). There was also a strong
negative correlation between capillary density and macro-
phage numbers in Group 2 (correlation¼0.443;
P¼ 0.001). There was no correlation between capillary
density and macrophage numbers when chronic damage
was less than 20% (Group 1).
When chronic damage was less than 20% (Group 1), there
was a significant correlation between urinary MCP-1/CCL2
and interstitial macrophages (correlation¼ 0.445; P¼ 0.001).
There was no significant correlation between urinary MCP-1/
CCL2 and interstitial macrophages with more advanced
chronic damage (Group 2).
Linear regression analysis for macrophage infiltration by
chronic damage group
By multivariate linear regression analysis, for Group 1, there
was a significant correlation between ACR and macrophage
numbers (correlation¼ 0.428; P¼ 0.005). MCP-1/CCL2 was
not significantly correlated indicating a direct relation-
ship with ACR. For Group 2, these patterns of associa-
tions changed. Interstitial capillary density independently
correlated with macrophage numbers (correlation¼ 0.479;
Po0.001). There was no significant correlation between
macrophages and ACR or MCP-1/CCL2.
Analysis by disease group
We assessed the relationship between the three largest disease
groups, focal segmental glomerulosclerosis, ischemic/hyper-
tensive nephropathy, and IgA nephropathy (Table 3). In
chronic damage Group 1, there was a significant difference
between these disease groups for macrophages (P¼ 0.001)
and ACR (P¼ 0.001). In chronic damage Group 2, there was
a significant difference for ACR (P¼ 0.001). There were no
significant differences for any other studied parameter.
However, by multivariate linear regression analysis with
chronic damage as the dependent variable, there was a highly
significant association with interstitial capillary density in all
disease states (Table 3), and a significant association with
macrophages in the IgA nephropathy group.
VEGF mRNA
cDNA was available for analysis for 33 patients in the cohort
(Figure 5). There were strong correlations with VEGF mRNA
DCt and capillary density (0.518; P¼ 0.002), macrophages
(0.654; Po0.001), and chronic damage (0.695;
Po0.001). The lower the DCt the lower the cycle number
at which VEGF mRNA is present in relationship to the
housekeeping gene, therefore, the higher the expression of
VEGF. So, the positive correlation seen with interstitial
capillary density means that higher levels of VEGF mRNA are
associated with lower capillary density; the inverse correla-
tions seen with macrophages and chronic damage means that
higher levels of VEGF mRNA are associated with increasing
macrophage infiltration and chronic damage.
When multivariate regression analysis was performed
incorporating VEGF mRNA with ACR, MCP-1/CCL2,
macrophage numbers, interstitial capillary density, and
chronic damage as variables, capillary density (0.647;
1460.001095.00730.00365.000.00
Time to renal end point (days)
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Cu
m
ul
at
ive
 re
na
l s
ur
viv
al
Peritubular
capillary density
(%)
<7
>10
7–10
<7-censored
>10-censored
7–10-censored
Figure 3 | Kaplan–Meier analysis of interstitial capillary
density on renal outcome. Interstitial capillary density
categorized into tertiles (Po0.03).
Table 2 | Univariate analysis of correlation between ACR, interstitial capillary density, urinary MCP-1/CCL2, interstitial
macrophage numbers, and index of chronic damage by chronic damage groups
Urinary ACR Capillary density Urinary MCP-1/CCL2 Interstitial macrophages
Chronic damage group Group 1 Group 2 Group 1 Group 2 Group 1 Group 2 Group 1 Group 2
Urinary ACR NA NA
Capillary density 0.101
NS
(52)
0.161
NS
(54)
NA NA
Urinary MCP-1/CCL2 0.529;
o0.001
(50)
0.483
o0.001
(46)
0.008
NS
(52)
0.004
NS
(47)
NA NA
Interstitial macrophages 0.619
o0.001
(49)
0.045
NS
(50)
0.188
NS
(51)
0.443
0.001
(52)
0.445
0.001
(48)
0.167
NS
(44)
NA NA
Chronic damage 0.337
0.015
(52)
0.116
NS
(54)
0.281
0.040
(54)
0.562
o0.001
(56)
0.076
NS
(51)
0.147
NS
(47)
0.524
o0.001
(51)
0.710
o0.001
(52)
ACR, albumin-to-creatinine ratio; MCP-1/CCL2, monocyte chemoattractant protein-1; NA, not applicable.
Group 1=chronic damage o20%; Group 2=chronic damage of 20%+.
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Po0.001) and VEGF mRNA DCt (0.336; P¼ 0.009)
showed significant associations.
CA IX expression
To further assess the relationship between hypoxia and in situ
determinants of chronic damage, we analyzed tissue from
patients with ischemic/hypertensive nephropathy (n¼ 20) for
CA IX, a transmembrane glycoprotein that is hypoxia
inducible and may therefore be an endogenous marker of
hypoxia. There was a significant difference between expres-
sion of CA IX in tissue with less than 20% chronic damage
and 20%þ chronic damage (Figure 6a–c). The large majority
of expression of CA IX was restricted to tubular epithelium.
CCR2 and CX3CR1 expression
The differential expression of two chemokine receptors
important for the recruitment and retention of macrophage
trafficking was assessed. Receptor expression appeared
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Figure 4 | Subgroup correlations: o20% chronic damage¼Group 1; 420% chronic damage¼Group 2 (correlation; P-value).
(a) ACR and macrophage infiltration: Group 1 (0.619; o0.001); Group 2 (NS); (b) ACR and chronic damage: Group 1 (0.337; 0.015);
Group 2 (NS); (c) capillary density and macrophage infiltration: Group 1 (NS); Group 2 (0.443; 0.001); and (d) capillary density and
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Table 3 | Multivariate linear regression analysis with chronic damage as the dependent variable.
Urinary ACR Capillary density Urinary MCP-1/CCL2 Interstitial macrophages
Focal segmental glomerulosclerosis b: 0.523
P=0.058
b: 1.139
P=0.001
b; 0.000
NS
b; 0.279
NS
Ischemia/hypertensive b: 0.20
NS
b: 0.646
Po0.001
b; 0.160
NS
b; 0.252
P=0.058
IgA b: 0.05
NS
b: 0.252
P=0.005
b; 0.068
NS
b; 0.831
Po0.001
ACR, albumin-to-creatinine ratio; IgA, immunoglobulin-A; MCP-1/CCL2, monocyte chemoattractant protein-1.
Note a highly significant association with interstitial capillary density in all disease states, and a significant association with macrophages in the IgA nephropathy subgroup.
(b=standardized b-coefficient).
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localized to cell infiltrates. The ratio between macrophage
infiltration and CCR2 expression was increased in biopsies
with 20%þ chronic damage compared with biopsies
with less than 20% chronic damage (Figure 6d–f), while
macrophage/CX3CR1 ratio was maintained (Figure 6g–i).
This indicates that CCR2 may have a more important role for
the recruitment of macrophages in early chronic damage. As
chronic damage progresses, the role for CX3CR1 for the
recruitment and retention of cells is maintained.
DISCUSSION
We have previously shown that albuminuria correlates with
MCP-1/CCL2 production in human chronic kidney disease
and may represent an important pathway for the recruitment
of macrophages to interstitial sites.2 We found the strongest
associations at lower levels of renal scarring; in more
advanced renal disease these associations were less strong.
To address the hypothesis that other factors may become
increasingly important as renal scarring develops, in these
studies we have analyzed the role of interstitial capillary
density, as a marker for tissue hypoxia. We demonstrate an
association between interstitial capillary loss, macrophage
recruitment, and chronic damage. Although there is a
significant correlation with MCP-1/CCL2 across the study
group, this is not an independent association.
In patients with renal scarring of 20% or more, levels that
may predict accelerated deterioration of renal function, we
found strong associations between capillary density, macro-
phage infiltration, and chronic damage. In patients with
lower levels of scarring (o20%), there was no correlation
between capillary density and macrophage numbers and a
weak correlation with chronic damage. This pattern was
reversed for albuminuria, with a strong association with
macrophage numbers (and MCP-1/CCL2 levels) in patients
with less than 20% scarring and no significant associations in
patients with scarring of 20% or more. These relationships
appeared independent of disease and indicate that in early
but not late renal damage, albuminuria and MCP-1/CCL2 are
important pathways for macrophage recruitment. As human
chronic kidney disease evolves, the relationship between
capillary density, macrophage recruitment and chronic
damage is of increasing importance. The lack of an
association between capillary density and MCP-1/CCL2
despite a strong association between capillary density and
macrophage numbers in more severe scarring (420%
chronic damage) is intriguing, and suggests that the
dominant pathways for macrophage recruitment and pro-
liferation in this setting may be MCP-1/CCL2 independent.
Progressive tubulointerstitial disease is associated with loss
of interstitial capillaries and reduced blood flow in those that
remain. Recent in vivo studies in animal models demon-
strated increased cortical tubular hypoxia with disease
progression using novel immunohistochemical markers.21,22
Tubulointerstitial hypoxia has also been demonstrated early
in the development of inflammation and injury, even before
capillary architecture perturbation.21 There is also evidence
of early tubulointerstitial hypoxia in human disease. In vivo
studies have demonstrated reduced peritubular capillary
flow preceding tubulointerstitial disease in patients with pro-
gressive forms of nephrotic syndrome compared with
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nonprogressive diseases where peritubular capillary flow is
preserved.23
Hypoxia may promote injury and scar formation by
pathways that include extracellular matrix production by
interstitial fibroblasts and proximal tubular epithelial cells
and the promotion of proximal tubular epithelial cells
transdifferentiation to fibroblasts.24,25 It also induces tubular
epithelial cell expression of proinflammatory molecules
including intercellular adhesion molecule-1 and tumor-
necrosis factor-a as well as inducing tubular apoptosis.19
Adaptive physiological response to hypoxia include
increased expression of VEGF and CA IX.26,27 VEGF is a
gene product of hypoxic pathways and has previously been
reported as showing increased expression in human chronic
kidney disease in association with loss of interstitial
capillaries.12,18 To further assess the in situ microenviron-
ment, we analyzed expression of VEGF mRNA and found a
direct relationship between VEGF mRNA production in situ,
interstitial capillary density, and macrophage infiltration. The
increased expression patterns of VEGF are consistent with
activation of hypoxic pathways in association with capillary
loss. The development of functional consequences of tissue
hypoxia with capillary loss was further supported in the
ischemic/hypertensive subgroup by upregulated CA IX
expression in biopsies with 20% or more chronic damage.
CA IX has been widely validated as a marker of hypoxia.28,29
Hypoxia may also downregulate inflammatory molecules,
indeed a recent in vitro study indicates that hypoxia
downregulates both constitutive expression and upregulation
by tumor-necrosis factor-a of MCP-1/CCL2 by proximal
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tubular epithelial cells.30 As chemokine receptors direct the
differential recruitment of cell subsets into the kidney,31,32
and MCP-1/CCL2 may be less important for macrophage
recruitment as chronic kidney disease progresses, we analyzed
CCR2 and CX3CR1 expression in ischemic/hypertensive
nephropathy. CCR2 is the targeted receptor for MCP-1/
CCL2; CX3CR1 is the fractalkine/CX3CL receptor, and may
contribute to the recruitment and retention of monocyte/
macrophages and other leukocyte subsets in human kidney
disease.32 MCP-1/CCL2 may enhance monocyte CX3CR1
recruitment and adhesion through CCR233 and as macro-
phages differentiate CCR2 expression may be downregulated
and CX3CR1 expression upregulated.34 Consistent with a
diminishing role for MCP-1/CCL2 in more advanced CKD,
there was a higher ratio of macrophage/CCR2 expression in
biopsies with 20%þ chronic damage. Conversely, for
CX3CR1, the expression ratio was maintained.
The balance between proteinuria and hypoxia in the
development of chronic kidney disease is of great interest. We
hypothesize that in early proteinuric disease, macrophages
are recruited by MCP-1/CCL2-dependent pathways. This
may be a focal process that represents the patchy nature of
disease and may localize macrophages to affected nephrons.
The majority of MCP-1/CCL2 in early disease will reflect
increased production of this chemokine by tubular epithelial
cells in response to albumin and other glomerular filtered
proteins. As nephron segments become scarred, ischemia
may then become a dominant factor in further promoting
macrophage infiltration and proliferation at these sites.
Hypoxic and angiogenic molecules are produced and
modulate the local microenvironment. These local processes
will then involve bystander nephrons, with the development
of both primary and secondary proteinuria and ischemia.
Although proteinuria will remain a surrogate marker for
disease progression as scarring progresses, it may be of less
pathogenic relevance in late disease. Indeed, it is now clear
that drugs that target the renin-angiotensin-aldosterone-
system have important direct anti-inflammatory as well as
antiproteinuric effects, which may explain their continuing
clinical efficacy in advanced renal disease.
The data reported here are observational and associative,
but do indicate that hypoxic damage secondary to oblitera-
tion of the interstitial capillary bed may represent an
important pathway in human chronic kidney disease for
the recruitment, and in situ retention and proliferation of
macrophages, the dominant infiltrating cell in the progres-
sion of chronic kidney disease.
MATERIALS AND METHODS
Patients
Following Local Ethical Committee permission and informed
consent, we recruited patients who underwent percutaneous renal
biopsy in our department for investigation of renal disease between
June 1999 and June 2002. Renal biopsy specimens were obtained and
fixed as previously indicated.2 Urine for quantification of MCP-1/
CCL2 was collected immediately before the biopsy.
Renal diagnosis
Renal diagnosis and exclusion criteria for further analysis have been
previously described.2 Histological diagnoses were made on formal
saline and glutaraldehyde-fixed biopsy specimens. Light microscopic
sections (2mm) were examined in orthodox ways and immuno-
staining done with an immunoperoxidase method for IgG, IgA,
IgM, and the complement component C9. The glutaraldehyde-fixed
specimen was embedded in Araldite and sectioned for electron
microscopy when indicated.
Urinary MCP-1/CCL2 assay
Quantification of urinary MCP-1/CCL2 was performed using a
commercially available sandwich ELISA kit according to the
manufacturers’ instructions (R&D Systems, Minneapolis, MN, USA).
These levels were corrected for urinary creatinine concentration.
Immunohistochemistry
Interstitial capillaries. The immunohistochemical detection of
tissue macrophages was performed as previously described.2 Briefly,
for interstitial capillaries, studies were performed on serial sections
using established methods. Sections were prepared for the applica-
tion of the primary antibody as previously described. There was then
sequential incubation with a primary mouse monoclonal antibody
directed against the endothelial cell marker CD34 (1 mg/ml; clone
QBEnd 10; Dako UK Ltd, Cambridgeshire, UK) for 1 h, a
biotinylated secondary rabbit anti-mouse antibody (50 mg/ml; Dako
Ltd) for 1 h and an HRP-conjugated streptavidin ABC complex
(Dako Ltd) for 20 min. Between each incubation periods, sections
were washed in Tris-buffered saline (pH 7.4). All incubations
were performed at room temperature. Binding was visualized
by the addition of 303-diaminobenzidine (Vector Laboratories
Ltd, Peterborough, UK). Mouse IgG1 (Dako Ltd) was used as an
isotype control antibody and substituted for the primary antibody
on serial sections. Tissue sections were batched over a short period
of 4 days to help maintain consistency in the technique used
between samples.
CCR2, CX3CR1, and CA IX. Biopsy sections from patients with
ischemic/hypertensive nephropathy were analyzed. Sections were
heated in an oven at 561C for 30 min and then placed in one-step
dewaxing and epitope retrieval solution W-Cap TEC Buffer pH
8.0AP (Surgipath Europe Ltd, Peterborough, UK) at 961C for
30 min. Sections were then allowed to cool in W-Cap for 20 min.
Sections were then treated with 0.3% solution of hydrogen peroxide
in methanol for 10 min. Endogenous biotin was blocked using a
sequential 10-min treatment with 0.1% avidin and 0.01% biotin
(Dako UK Ltd). For CA IX antigen retrieval, the citrate buffer
epitope retrieval method was used instead of W-Cap one-step
dewaxing and epitope retrieval technique.
Chemokine receptor expression was studied with a CCR2
rabbit anti-human monoclonal antibody ([ab32144]; Abcam plc,
Cambridge, UK) at 1:300 dilution, and CX3CR1 by a rabbit anti-
human polyclonal antibody ([AB1891]; Chemicon Europe Ltd,
Hampshire UK) at a 1:125 dilution. CA IX was studied by a rabbit
anti-human polyclonal antibody ([ab15086]; Abcam plc, dilution
1:500), diluted in Dako REAL Antibody Diluent (S2022; Dako UK
Ltd) for 60 min at room temperature. ChemMate DAKO EnVision
Detection kit (K5007; Dako UK Ltd) was used for detection of
positive staining. In this two-step technique, sections were incubated
with the ChemMate DAKO EnVision/HRP, rabbit/mouse reagent for
30 min. Following which, sections were washed with phosphate-
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buffered saline and then incubated with 1:40 dilution of ChemMate
DABþChromogen in ChemMate Substrate Buffer for 10 min.
Sections were then mounted in an aqueous medium (Immumount;
Life Sciences International, Basingstoke, Hants, UK).
Controls used included omission of the primary antibody and
substitution with an irrelevant rabbit IgG (Dako UK Ltd) isotype
control at equivalent concentrations in parallel using adjacent
sections on the same slide. Sections from renal cell carcinoma tissue
were used as positive controls for CA IX staining.
In situ quantification
An interactive image analysis system was used for quantitative
assessment of in situ antigens as previously described.2 Coded
sections were stained for CD68, CD34, CCR2, CX3CR1, and CA IX,
and the image captured digitally, converted to a two-color scale
image and processed. For each patient, the mean measurement of
five randomly selected nonconfluent microscopic fields of renal
cortex was determined. Glomerular staining was excluded from the
analysis by the computer software.
Quantification of chronic damage
Chronic damage was assessed as previously described.2,35
Real-time PCR
Expression of mRNA for VEGF was assessed using real-time PCR in
an ABI 7500 system (Applied Biosystems, Warrington, UK). mRNA
had been isolated and reverse transcribed for 33 patients of the
original cohort as previously described.36 The reactions were
performed in 25 ml aliquots on a 96-well optical reaction plate
(Applied Biosystems). Primers for 18 s were used in conjunction
with target primers as an internal reference. Reactions contained
TaqMan universal PCR master mix (Applied Biosystems),
500–900 nmol primers, 100–200 nmol TaqMan probe, and 25–50 ng
cDNA. Target gene probes were labeled with FAM and 18 s probes
were labeled with VIC. Reactions occurred as follows: 501C for
2 min, 951C for 10 min, 44 cycles of 951C for 15 s, and 601C for
1 min. Data were obtained as Ct values (the cycle number at which
logarithmic PCR plots cross a calculated threshold line) according to
the manufacture’s guidelines, and used to determine DCt values
(Ct of target geneCt of housekeeping gene) as raw data for gene
expression. TaqMan gene expression assays for VEGF (ID:
Hs00900054_m1) were purchased from Applied Biosystems.
Statistics
The validity of the methods was assessed as previously outlined and
extended to include the other determinants.2 Linear regression
analyses were performed to determine correlations between normally
distributed data variables. When required, as determined by
normality testing for skewness, data variables were normalized by
log transformation. Correlations are presented by expressing the
b-correlation coefficient along with the P-value. Comparison of data,
mean or median, was performed using a two-tailed t-test, where data
were normally distributed and a Mann–Whitney or Kruskal–Wallis
test, where the data were not parametric. Renal outcome was also
assessed by Kaplan–Meier survival analysis with logrank testing for
interstitial capillary density after categorization in tertiles. All
statistical tests were performed using SPSS for Windows, version 14.0.
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